The mean of analysts' price targets for Day One Biopharmaceuticals (DAWN) points to a 107.4% upside in the stock. While this ...
Zacks.com on MSN
Wall Street Analysts See a 26.38% Upside in Cloudflare (NET): Can the Stock Really Move This High?
Cloudflare (NET) closed the last trading session at $197.53, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
Zacks.com on MSN
Does Daktronics (DAKT) Have the Potential to Rally 29.17% as Wall Street Analysts Expect?
Daktronics (DAKT) closed the last trading session at $19.61, gaining 6.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results